Alexandria Real Estate Equities-backed genome engineering platform developer Synthego took its overall funding to $160m in a round led by Founders Fund.
Synthego, a US-based genome engineering technology developer backed by life sciences real estate developer Alexandria Real Estate Equities, has secured $110m in a series C round.
Founders Fund led the round, which also featured fellow venture capital firms 8VC and Menlo Ventures, increasing Synthego’s overall funding to $160m.
Founded in 2012, Synthego has created a genome engineering platform for use in the development of cell and gene therapies.
The platform utilises automation, bioinformatics, and machine learning technology, and allows researchers…
